Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Fate Therapeutics
DualityBio Inc.
Seagen Inc.
Puma Biotechnology, Inc.
Fate Therapeutics
Incyte Corporation
Silverback Therapeutics
Fate Therapeutics
NKGen Biotech, Inc.
AEterna Zentaris
BBB-Therapeutics B.V.